Hub Group Restates Financials After $77M Accounting Error Discovery

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Hub Group restates financials after discovering $77M accounting error in transportation costs. Stock dropped 25%, though cash flow unaffected.

Hub Group Restates Financials After $77M Accounting Error Discovery

Hub Group Inc. disclosed a significant accounting error totaling $77 million related to purchased transportation costs and accounts payable, requiring a restatement of previously reported financial results. The logistics company announced the discovery on February 6, 2026, coinciding with the release of preliminary fourth-quarter and full-year 2025 results. The company delayed filing updated financial statements to reflect the corrections.

The restatement triggered an immediate market reaction, with Hub Group's stock declining approximately 25% during intraday trading following the announcement. However, the company emphasized that the accounting adjustment did not affect its cash flow position, suggesting the error was primarily a balance sheet matter rather than an operational cash concern.

The disclosure prompted investigation by securities counsel Faruqi & Faruqi, LLP on behalf of investors. The firm's involvement indicates potential shareholder litigation related to the accounting irregularities and the impact on investor confidence prior to the public disclosure of the error.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 15

Related Coverage

GlobeNewswire Inc.

Weis Markets Faces Accounting Restatement, Stock Plunges as Law Firm Probes Securities Violations

Weis Markets restating financials for 2022-2024 due to overstated inventory; stock drops 7.16%. Law firm investigates potential securities law violations.

WMK
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX
GlobeNewswire Inc.

Nektar Therapeutics Faces Class Action Over Failed Trial Data Disclosure

Pomerantz LLP filed securities fraud class action against Nektar Therapeutics, alleging false statements about clinical trial enrollment procedures led to trial failure and stock decline.

NKTR